Documento completo  |  Capítulo completo  |  Expandir índice  |  Versión HTML imprimible
Globalization and Access to Drugs. Perspectives on the WTO/TRIPS Agreement - Health Economics and Drugs Series, No. 007 (Revised)
(1998; 97 pages) [French] [Spanish] Ver el documento en el formato PDF
Documentos relacionados
Resumen
The aim of this document is to inform people in the health sector with no particular legal background about the impact of globalization on access to drugs, and especially about the WTO agreement on intellectual property (TRIPS Agreement) that may have repercussions in the pharmaceutical field. Therefore, the paper is meant to be non-technical in nature and does not deal with all aspects of patents nor of the TRIPS Agreement, but examines the Agreement only from the perspective of public health and access to drugs. The first part gives an introduction to the international trade system from the GATT to the WTO. The second part analyses the section on patents of the TRIPS Agreement in relation to access to essential drugs.
Índice de contenido
Ver el documentoAcknowledgements
Ver el documentoAbbreviations and acronyms
Abrir esta carpeta y ver su contenidoPART I: GLOBALIZATION AND ACCESS TO DRUGS: IMPLICATIONS OF THE WTO/TRIPS AGREEMENT
Abrir esta carpeta y ver su contenidoPART II: PRESENTATIONS AT THE AD HOC WORKING GROUP ON THE REVISED DRUG STRATEGY HELD IN GENEVA ON 13 OCTOBER 1998
Ver el documentoOther documents in the DAP - Health Economics and Drugs Series
Ver el documentoBack cover
 

Globalization and Access to Drugs. Perspectives on the WTO/TRIPS Agreement - Health Economics and Drugs Series, No. 007 (Revised)

Health Economics and Drugs
DAP Series No. 7
Revised

WHO/DAP/98.9
Original: French
Distribution: General

World Health Organization
Action Programme on Essential Drugs

 

Ir a la siguiente sección
 
 
El Portal de Información - Medicamentos Esenciales y Productos de Salud de la OMS fue diseñado y es mantenido por la ONG Human Info. Última actualización: le 25 junio 2014